ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ozdog
|
261 |
63K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
63K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ozdog
|
261 |
63K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
63K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
ozdog
|
126 |
31K |
11 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
31K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
ozdog
|
126 |
31K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
31K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
ozdog
|
196 |
36K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
ozdog
|
111 |
34K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
111
|
34K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
ozdog
|
209 |
49K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
ozdog
|
209 |
49K |
9 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
ozdog
|
1.3K |
326K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
1.3K
|
326K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
ozdog
|
1.3K |
326K |
12 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
1.3K
|
326K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
ozdog
|
197 |
51K |
22 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
51K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust brand name required
|
|
ozdog
|
30 |
6.0K |
6 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
30
|
6.0K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: New Hires & Attendance at International MND Symposium
|
|
ozdog
|
56 |
12K |
40 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
56
|
12K
|
40
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
ozdog
|
125 |
24K |
7 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
24K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ozdog
|
106 |
21K |
14 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
106
|
21K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
ozdog
|
380 |
83K |
21 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
380
|
83K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
ozdog
|
380 |
83K |
10 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
380
|
83K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust launches international CEO search
|
|
ozdog
|
95 |
23K |
9 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
95
|
23K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Multi Blockbuster Share??
|
|
ozdog
|
73 |
17K |
13 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
73
|
17K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Cancer Trial Update
|
|
ozdog
|
220 |
42K |
6 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
220
|
42K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: DNDi contract extension for PharmAust subsidiary Epichem
|
|
ozdog
|
14 |
3.7K |
4 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
14
|
3.7K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Where are you PAA ????
|
|
ozdog
|
33 |
7.1K |
10 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
33
|
7.1K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Where are you PAA ????
|
|
ozdog
|
33 |
7.1K |
4 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
33
|
7.1K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Where are you PAA ????
|
|
ozdog
|
33 |
7.1K |
8 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
33
|
7.1K
|
8
|
|
ASX - By Stock
|
PAA |
Where are you PAA ????
|
|
ozdog
|
33 |
7.1K |
17 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
33
|
7.1K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ozdog
|
1.4K |
369K |
16 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
1.4K
|
369K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ozdog
|
1.4K |
369K |
11 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
1.4K
|
369K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ozdog
|
1.4K |
369K |
18 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
1.4K
|
369K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
ozdog
|
360 |
81K |
14 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
360
|
81K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
ozdog
|
1.4K |
369K |
11 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
1.4K
|
369K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
ozdog
|
360 |
81K |
9 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
360
|
81K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
ozdog
|
360 |
81K |
4 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
360
|
81K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
ozdog
|
360 |
81K |
7 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
360
|
81K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed
|
|
ozdog
|
134 |
37K |
10 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
134
|
37K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
ozdog
|
42 |
6.3K |
9 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
42
|
6.3K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
ozdog
|
360 |
81K |
5 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
360
|
81K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Channel 7 News Tonight
|
|
ozdog
|
31 |
7.3K |
9 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
31
|
7.3K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem Completes Build of OHD Benchtop Flow Reactor
|
|
ozdog
|
53 |
10K |
4 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
53
|
10K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Why is our SP so low?
|
|
ozdog
|
38 |
8.8K |
11 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
38
|
8.8K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
ozdog
|
732 |
144K |
25 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
732
|
144K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ozdog
|
39 |
10K |
7 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
39
|
10K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Some scientific inspiration
|
|
ozdog
|
27 |
5.0K |
3 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
27
|
5.0K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
HC PAA SH Volume
|
|
ozdog
|
180 |
40K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
180
|
40K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Fast Track Approval Pathway MPL V Covid-19
|
|
ozdog
|
118 |
26K |
3 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
118
|
26K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Fast Track Approval Pathway MPL V Covid-19
|
|
ozdog
|
118 |
26K |
7 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
118
|
26K
|
7
|
|
ASX - By Stock
|
PAA |
Small caps announcement
|
|
ozdog
|
26 |
8.0K |
7 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
26
|
8.0K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
WALTER AND ELIZA HALL INSTITUTE RESEARCH MPL Vs CV-19 Results 100% Success Guaranteed Everytime.
|
|
ozdog
|
65 |
18K |
11 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
65
|
18K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Report delivered under Option Agreement
|
|
ozdog
|
461 |
92K |
5 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
461
|
92K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Report delivered under Option Agreement
|
|
ozdog
|
461 |
92K |
15 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
461
|
92K
|
15
|
|
ASX - By Stock
|
PAA |
Monepantel ??? Further Properties
|
|
ozdog
|
6 |
2.3K |
20 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
6
|
2.3K
|
20
|
|